Perkins Capital Management’s Sonnet BioTherapeutics SONN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$110K	–	133
2018 Q3	$110K	Hold	1	–	–	0.07%	121
2018 Q2	$210K	Buy	+1	New	+$210K	0.15%	111